Construction of CpG Delivery Nanoplatforms by Functionalized MoS2 Nanosheets for Boosting Antitumor Immunity in Head and Neck Squamous Cell Carcinoma

Le résumé fourni par la source

Abstract Despite the promising achievements of immune checkpoint blockade (ICB) therapy for tumor treatment, its therapeutic effect against solid tumors is limited due to the suppressed tumor immune microenvironment (TIME). Herein, a series of polyethyleneimine (Mw = 0.8k, PEI0.8k)‐covered MoS2 nanosheets with different sizes and charge densities are synthesized, and the CpG, a toll‐like receptor‐9 agonist, is enveloped to construct nanoplatforms for the treatment of head and neck squamous cell carcinoma (HNSCC). It is proved that functionalized nanosheets with medium size display similar CpG loading capacity regardless of low or high PEI0.8k coverage owing to the flexibility and crimpability of 2D backbone. CpG‐loaded nanosheets with medium size and low charge density (CpG@MM‐PL) could promote the maturation, antigen‐presenting capacity, and proinflammatory cytokines generation of bone marrow‐derived dendritic cells (DCs). Further analysis reveals that CpG@MM‐PL effectively boosts the TIME of HNSCC in vivo including DC maturation and cytotoxic T lymphocyte infiltration. Most importantly, the combination of CpG@MM‐PL and ICB agents anti‐programmed death 1 hugely improves the tumor therapeutic effect, inspiring more attempts for cancer immunotherapy. In addition, this work uncovers a pivotal feature of the 2D sheet‐like materials in nanomedicine development, which should be considered for the design of future nanosheet‐based therapeutic nanoplatforms.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.